New Dementia Treatments Today

1. Described the key necessary diagnostic clinical and biomarkers requirements for the diagnosis of Alzheimer’s Disease.
2. Summary of present classification for the clinical stages of Alzheimer’s Disease.
3. Summarize the recent FDA approved disease modifying therapies; as well as, being familiar with present research therapies for Alzheimer’s Disease.

Dr. Paul Winner, has no actual or potential conflict of interest in relation to this program or presentation.

The FOMA is accredited by the American Osteopathic Association to provide Osteopathic continuing medical education for Physicians.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Osteopathic Association (AOA). The Florida Osteopathic Medical Association (FOMA) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.

GRIEVANCE POLICY: The FOMA strives to provide continuing medical education programs to fulfill the needs of the attendees and to meet the AOA Uniform Guidelines and AOA Accreditation Requirements. Comments, questions, or complaints should be forwarded to FOMA Executive Director Steve Winn, by calling the FOMA Office at 850-878-7364 or by mail to FOMA, 2544 Blairstone Pines Drive, Tallahassee, FL  32301, or by email to admin@foma.org